Trial Profile
Clinical response of sipuleucel-T in patients with castrate-resistant prostate cancer (CRPC) to identify biologic and inflammatory markers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Sipuleucel-T (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 16 Dec 2015 New trial record